Argus Research Maintains Buy on DexCom, Raises Price Target to $96
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Argus Research analyst Steve Silver maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $86 to $96.
Argus Research analyst Steve Silver maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $86 to $96.